See What HealthDay Can Do For You
Contact Us

ACAAI: Non-Allergists Differ in Approach to Food Allergies

More non-allergists use unproven methods for diagnosis and treatment

MONDAY, Nov. 20 (HealthDay News) -- A survey suggests that non-allergists are more likely to use unproven methods to diagnose and treat food allergies compared with allergists, according to a study presented Nov. 12 at the annual meeting of the American College of Allergy, Asthma & Immunology in Philadelphia.

Sami L. Bahna, M.D., from Louisiana State University Medical Center in Shreveport, and colleagues surveyed 584 allergists and 77 non-allergists (internists, family practitioners, pediatricians and otolaryngologists) on their approaches to the diagnosis, treatment and prevention of food allergies. The subjects completed a two-page questionnaire.

The researchers found that a smaller percentage of non-allergists recommended proven diagnostic methods such as sIgE and oral challenges and instead recommended methods such as leukocytotoxic tests and sIgG4. More non-allergists considered open and single-blind challenges inadequate for patients under six years of age. More non-allergists used treatment methods such as conventional elimination diets and rotation diets rather than elimination of proven food allergens, according to the study.

"There are marked variations between non-allergist and allergist physicians in the reported causes, methods of diagnosis, treatment and prevention of food allergy," Bahna and colleagues conclude. "More non-allergists than allergists utilize unproven methods of diagnosis and treatment."

For more information, go to the Web site of the ACAAI's annual meeting (More Information).

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.